Medical Disclaimer

MedAtlas is designed for use by physicians, physician assistants, nurse practitioners, registered nurses, paramedics, pharmacists, and clinical trainees who are operating within the scope of their license and under any required supervision. The content is written at a level that assumes a working clinical vocabulary and a foundation in pharmacology, microbiology, and clinical decision-making.

MedAtlas is not designed for patients, caregivers, or members of the public seeking medical advice. If you are not a healthcare professional, please consult a qualified clinician for any health concern; do not rely on the App for self-diagnosis or self-treatment.

The content in MedAtlas — including calculators, drug references, syndrome summaries, treatment regimens, protocols, procedure guides, and decision algorithms — is provided for educational and reference purposes only. It is intended to support, not replace, the professional judgment of the clinician at the bedside.

Nothing in the App constitutes medical advice for any specific patient. The App does not, and cannot, take into account a particular patient's full medical history, allergies, contraindications, comorbidities, current medications, or local protocols. The clinician is solely responsible for integrating any reference information with the specific facts of the patient in front of them.

Medical knowledge changes rapidly. Society guidelines are updated; new evidence emerges; drug labels and formularies change; resistance patterns evolve. We make reasonable efforts to keep MedAtlas current, but we cannot guarantee that any individual entry reflects the most recent guideline or the most current literature.

Before acting on any dose, regimen, threshold, or recommendation in the App, you are responsible for verifying it against authoritative current references appropriate to the situation. These include, at minimum: the current package insert (label) for any medication; the current formulary and protocol of your institution; the most recent guideline published by the relevant professional society; and, where applicable, a clinical pharmacist, toxicologist, or specialty consult.

When MedAtlas and a current authoritative source disagree, the authoritative source governs.

Many institutions and emergency medical services have local protocols that govern empiric antibiotic choices, sedation, advanced airway management, mass-transfusion thresholds, and other interventions. These local protocols are often tuned to local resistance patterns, available formulary, staffing, and regulatory environment.

Where your institution's protocol applies, follow it. MedAtlas is provided as an external reference, not as a substitute for or override of any local policy.

Each treatment regimen, calculator, and decision pathway in MedAtlas is linked to a citation visible within the App. We strongly encourage you to consult the underlying source before acting on the App's summary, especially for high-stakes decisions or for any patient population the source did not study.

Where a regimen is derived from a single primary trial or society document, the App identifies that source. Where a regimen reflects consensus across multiple sources, the App cites the most recent or most authoritative.

Particular caution is required when applying any reference content to special populations, including but not limited to: pediatric patients (especially neonates and infants); pregnant or lactating patients; geriatric patients with renal or hepatic dysfunction; patients with end-stage renal disease on dialysis; patients with hepatic failure; immunocompromised patients; patients with rare or complex comorbidities; and patients with significant drug-drug interactions.

MedAtlas calculators and regimens are written for typical adult patients unless explicitly labeled otherwise. Pediatric dosing within the App, where present, generally relies on weight-based or BSA-based calculations whose accuracy depends on accurate input. Verify pediatric doses against a pediatric-specific reference (such as Lexicomp Pediatric, Harriet Lane, or your institution's pediatric formulary) before administration.

MedAtlas does not perform automated drug-allergy checking or drug-interaction screening. Before prescribing or administering any medication, you are responsible for confirming that the patient has no documented allergy or hypersensitivity to the agent or its excipients, no contraindication based on comorbidity or concurrent therapy, and no clinically significant interaction with the patient's current medications.

Where an interaction is well known and clinically critical (for example, MAOIs with serotonergic agents, or contrast media with metformin in advanced CKD), MedAtlas may note the interaction within the relevant entry. The absence of an interaction notice in MedAtlas does not imply that no interaction exists.

In a true emergency, call 911 (or your local emergency number) immediately. For suspected poisoning or overdose in the United States, contact Poison Control at 1-800-222-1222 — they provide free, expert, 24-hour consultation. MedAtlas is a reference; it is not a replacement for emergency services, poison control, or in-person clinical care.

Use of MedAtlas does not create any doctor-patient, advisor-client, or other professional relationship between you and the developer of the App, between any patient and the developer, or between any patient and you (other than the relationship that arises independent of the App in the course of your professional practice).

The content of MedAtlas is provided "as is," without warranty of any kind. While we make good-faith efforts to ensure accuracy, we make no representation or warranty as to the completeness, accuracy, timeliness, or fitness for any particular purpose of any content in the App. The developer expressly disclaims any liability for actions taken in reliance on the content of the App. See the Terms of Service for the formal limitation-of-liability provisions.

MedAtlas is developed primarily with reference to United States society guidelines (such as IDSA, AHA, ACC, ACEP, ACOG, AAP) and United States Food and Drug Administration prescribing information. Practice patterns, available formulary, regulatory requirements, and approved indications vary by country and region. If you practice outside the United States, consult guidelines and labeling appropriate to your jurisdiction.

If you identify content in MedAtlas that you believe is incorrect, outdated, or potentially harmful, please contact us immediately at support@usemedatlas.com. We take such reports seriously and investigate them promptly. Where appropriate, we update the content and credit the reporter in our release notes.

Reporting an error in MedAtlas does not replace the obligation to report a clinical event through your institution's incident reporting system, to the manufacturer of the implicated product where applicable, and (in the United States) to MedWatch (https://www.fda.gov/safety/medwatch) for drug or device-related adverse events.

By using MedAtlas, you acknowledge that you have read this Medical Disclaimer, that you are an Authorized User as described in the Terms of Service, and that you accept full professional responsibility for any clinical action taken in connection with your use of the App.